Fig. 3From: Comparison of fully-automated radiosyntheses of [11C]erlotinib for preclinical and clinical use starting from in target produced [11C]CO2 or [11C]CH4Semi-preparative chromatogram of the reaction solution of [11C]erlotinib (top: UV-channel; bottom: radioactivity-channel) for method 1 (a) and method 2 (b). Note that flow rate was 8 mL/min for method 1 and 2.5 mL/min for method 2Back to article page